{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:41:07Z","timestamp":1768434067416,"version":"3.49.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology Case Reports"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.eucr.2019.100858","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T09:24:28Z","timestamp":1551777868000},"page":"100858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Malignant pheochromocytoma with negative biochemical markers: Is it time to reclassify pheochromocytomas?"],"prefix":"10.1016","volume":"24","author":[{"given":"Shiva","family":"Borzouei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Habibollah","family":"Mousavi-bahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed Ahmadreza","family":"Salimbahrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mher","family":"Sardari Masihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eucr.2019.100858_bib1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eucr.2019.100858_bib2","first-page":"86","article-title":"Pheochromocytoma: an uncommon presentation of an asymptomatic and biochemically silent adrenal incidentaloma","volume":"19","author":"Kumar","year":"2012","journal-title":"Malays J Med Sci: MJMS"},{"key":"10.1016\/j.eucr.2019.100858_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6270436","article-title":"Marker-negative pheochromocytoma associated with inferior vena cava thrombosis","volume":"2017","author":"Poudyal","year":"2017","journal-title":"Case reports in urology"},{"issue":"5","key":"10.1016\/j.eucr.2019.100858_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jso.24031","article-title":"Pheochromocytoma diagnosed pathologically with previous negative serum markers","volume":"112","author":"Heavner","year":"2015","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1016\/j.eucr.2019.100858_bib5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"Jama"}],"container-title":["Urology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442019300403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442019300403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:55:29Z","timestamp":1762001729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214442019300403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":5,"alternative-id":["S2214442019300403"],"URL":"https:\/\/doi.org\/10.1016\/j.eucr.2019.100858","relation":{},"ISSN":["2214-4420"],"issn-type":[{"value":"2214-4420","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant pheochromocytoma with negative biochemical markers: Is it time to reclassify pheochromocytomas?","name":"articletitle","label":"Article Title"},{"value":"Urology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eucr.2019.100858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100858"}}